A prospective, multicentre first-in-man study of the polymer-free ultrathin-strut BIOrapid stent (BIOVITESSE)

CONCLUSIONS: The BIOrapid stent system exhibited an excellent safety profile, high strut coverage at one month, and moderate angiographic efficacy according to the late lumen loss at nine-month angiographic follow-up.PMID:34794936 | DOI:10.4244/EIJ-D-21-00537

Source: EuroIntervention - November 19, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Lorenz R äber Jonas Dominik H äner Thomas F L üscher Marco Moccetti Marco Roffi Stefan Stortecky Olivier Muller Hector M Garcia-Garcia Ron Waksman Patrick Siegrist Source Type: research